CHARLESTON, S.C., April 19, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical or the "Company") (OTCQB:RMCP) announced today that the Company will attend the IDN Summit, April 23-25, 2012 in Orlando, FL. IDN Summit's unique reverse expo format provides an efficient and effective venue for networking opportunities, meetings and idea exchange among all sectors of the supply chain. Healthcare-purchase decision makers can source new vendors from the hundreds of companies participating at the IDN Summit and Reverse Expo. Most of the U.S.-based syringe distributors will be in attendance and will get their first introduction to the next generation safety syringe, the RevVac™ auto-retractable vacuum safety syringe.
The Company is focusing its attention on U.S. distributors this quarter to help penetrate its unique product further into the U.S. healthcare market. The Company, through its international distribution network, already has sales commitments for 2.5 million RevVac™ safety syringes per month.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated "I am looking forward to follow up meetings with many U.S. distributors that are already familiar with our RevVac™ safety syringe and to meet with new potential distributors that will see our unique product for the first time." He continued, the IDN Summit and Reverse Expo is a perfect opportunity for our Company to showcase our syringe because many of the significant distribution companies, along with their key decision makers, will all be under one roof at the same time."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ safety syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website:
http://www.revolutionsmedical.com
To be added to the Revolutions Medical investor email list, please email:
investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.